Related references
Note: Only part of the references are listed.Gilenya (FTY720) inhibits acid sphingomyelinase by a mechanism similar to tricyclic antidepressants
Glyn Dawson et al.
BIOCHEMICAL AND BIOPHYSICAL RESEARCH COMMUNICATIONS (2011)
Drug targeting of sphingolipid metabolism: sphingomyelinases and ceramidases
Daniel Canals et al.
BRITISH JOURNAL OF PHARMACOLOGY (2011)
Acid Sphingomyelinase Inhibitors Normalize Pulmonary Ceramide and Inflammation in Cystic Fibrosis
Katrin Anne Becker et al.
AMERICAN JOURNAL OF RESPIRATORY CELL AND MOLECULAR BIOLOGY (2010)
Functional Inhibitors of Acid Sphingomyelinase (FIASMAs): A Novel Pharmacological Group of Drugs with Broad Clinical Applications
Johannes Kornhuber et al.
CELLULAR PHYSIOLOGY AND BIOCHEMISTRY (2010)
Cheminformatics approaches to analyze diversity in compound screening libraries
Lakshmi B. Akella et al.
CURRENT OPINION IN CHEMICAL BIOLOGY (2010)
Prediction of passive blood-brain partitioning: Straightforward and effective classification models based on in silico derived physicochemical descriptors
Santiago Vilar et al.
JOURNAL OF MOLECULAR GRAPHICS & MODELLING (2010)
Deregulation of sphingolipid metabolism in Alzheimer's disease
Xingxuan He et al.
NEUROBIOLOGY OF AGING (2010)
Therapeutic Efficacy and Safety of Amitriptyline in Patients with Cystic Fibrosis
Joachim Riethmueller et al.
CELLULAR PHYSIOLOGY AND BIOCHEMISTRY (2009)
Roles and regulation of secretory and lysosomal acid sphingomyelinase
Russell W. Jenkins et al.
CELLULAR SIGNALLING (2009)
The role of ceramide in major depressive disorder
Johannes Kornhuber et al.
EUROPEAN ARCHIVES OF PSYCHIATRY AND CLINICAL NEUROSCIENCE (2009)
Parameterization of an empirical model for the prediction of n-octanol, alkane and cyclohexane/water as well as brain/blood partition coefficients
Mohamed Zerara et al.
JOURNAL OF COMPUTER-AIDED MOLECULAR DESIGN (2009)
Ionization-Specific Prediction of Blood-Brain Permeability
Kiril Lanevskij et al.
JOURNAL OF PHARMACEUTICAL SCIENCES (2009)
Spinal Ceramide Modulates the Development of Morphine Antinociceptive Tolerance via Peroxynitrite-Mediated Nitroxidative Stress and Neuroimmune Activation
Michael M. Ndengele et al.
JOURNAL OF PHARMACOLOGY AND EXPERIMENTAL THERAPEUTICS (2009)
PubChem: a public information system for analyzing bioactivities of small molecules
Yanli Wang et al.
NUCLEIC ACIDS RESEARCH (2009)
INHIBITION OF CERAMIDE BIOSYNTHESIS AMELIORATES PATHOLOGICAL CONSEQUENCES OF SPINAL CORD INJURY
Salvatore Cuzzocrea et al.
SHOCK (2009)
Lysosomal Targeting and Trafficking of Acid Sphingomyelinase to Lipid Raft Platforms in Coronary Endothelial Cells
Si Jin et al.
ARTERIOSCLEROSIS THROMBOSIS AND VASCULAR BIOLOGY (2008)
Enriched random forests
Dhammika Amaratunga et al.
BIOINFORMATICS (2008)
Alternative contingency table measures improve the power and detection of multifactor dimensionality reduction
William S. Bush et al.
BMC BIOINFORMATICS (2008)
Changes in sphingomyelinases, ceramide, Bax, Bcl2, and caspase-3 during and after experimental status epilepticus
Mohamad A. Mikati et al.
EPILEPSY RESEARCH (2008)
Quantitative modeling of selective lysosomal targeting for drug design
Stefan Trapp et al.
EUROPEAN BIOPHYSICS JOURNAL WITH BIOPHYSICS LETTERS (2008)
Predicting blood-brain barrier penetration from molecular weight and number of polar atoms
Xu-Chun Fu et al.
EUROPEAN JOURNAL OF PHARMACEUTICS AND BIOPHARMACEUTICS (2008)
The unexpected role of acid sphingomyelinase in cell death and the pathophysiology of common diseases
Eric L. Smith et al.
FASEB JOURNAL (2008)
Size-intensive descriptors
George D. Purvis
JOURNAL OF COMPUTER-AIDED MOLECULAR DESIGN (2008)
Identification of new functional inhibitors of acid sphingomyelinase using a structure-property-activity relation model
Johannes Kornhuber et al.
JOURNAL OF MEDICINAL CHEMISTRY (2008)
High throughput lipidomic profiling of schizophrenia and bipolar disorder brain tissue reveals alterations of free fatty acids, phosphatidylcholines, and ceramides
Emanuel Schwarz et al.
JOURNAL OF PROTEOME RESEARCH (2008)
Ceramide accumulation mediates inflammation, cell death and infection susceptibility in cystic fibrosis
Volker Teichgraeber et al.
NATURE MEDICINE (2008)
Acid sphingomyelinase deficiency protects from cisplatin-induced gastrointestinal damage
A. Rebillard et al.
ONCOGENE (2008)
QSAR modeling of the Blood-Brain Barrier permeability for diverse organic compounds
Liying Zhang et al.
PHARMACEUTICAL RESEARCH (2008)
Artificial neural networks in ADMET modeling:: Prediction of blood-brain barrier permeation
Angela Guerra et al.
QSAR & COMBINATORIAL SCIENCE (2008)
A review of feature selection techniques in bioinformatics
Yvan Saeys et al.
BIOINFORMATICS (2007)
Benchmarking and validating algorithms that estimate pKa values of drugs based on their molecular structures
Milan Meloun et al.
ANALYTICAL AND BIOANALYTICAL CHEMISTRY (2007)
Acid sphingomyelinase inhibition suppresses lipopolysaccharide-mediated release of inflammatory cytokines from macrophages and protects against disease pathology in dextran sulphate sodium-induced colitis in mice
Akira Sakata et al.
IMMUNOLOGY (2007)
Modelling of the blood-brain barrier in drug discovery and development
Romeo Cecchelli et al.
NATURE REVIEWS DRUG DISCOVERY (2007)
Reactive nitrogen and oxygen species activate different sphingomyelinases to induce apoptosis in airway epithelial cells
S. Sianna Castillo et al.
EXPERIMENTAL CELL RESEARCH (2007)
Benchmarking of QSAR models for blood-brain barrier permeation
Dmitry A. Konovalov et al.
JOURNAL OF CHEMICAL INFORMATION AND MODELING (2007)
Recent advances in the immunobiology of ceramide
Saumya Pandey et al.
EXPERIMENTAL AND MOLECULAR PATHOLOGY (2007)
Similarity-based virtual screening using 2D fingerprints
Peter Willett
DRUG DISCOVERY TODAY (2006)
Novel 2D fingerprints for ligand-based virtual screening
Todd Ewing et al.
JOURNAL OF CHEMICAL INFORMATION AND MODELING (2006)
In silico prediction of blood - Brain barrier permeation using the calculated molecular cross-sectional area as main parameter
Gregori Gerebtzoff et al.
JOURNAL OF CHEMICAL INFORMATION AND MODELING (2006)
A data base for partition of volatile organic compounds and drugs from blood/plasma/serum to brain, and an LFER analysis of the data
Michael H. Abraham et al.
JOURNAL OF PHARMACEUTICAL SCIENCES (2006)
New insights on the use of desipramine as an inhibitor for acid ceramidase
Saeed Elojeimy et al.
FEBS LETTERS (2006)
Reverse fingerprinting, similarity searching by group fusion and fingerprint bit importance
Chris Williams
MOLECULAR DIVERSITY (2006)
Soluble oligomers of amyloid-β peptide induce neuronal apoptosis by activating a cPLA2-dependent sphingomyelinase-ceramide pathway
Catherine Malaplate-Armand et al.
NEUROBIOLOGY OF DISEASE (2006)
Statistics notes - The cost of dichotomising continuous variables
DG Altman et al.
BRITISH MEDICAL JOURNAL (2006)
CNS permeability of drugs predicted by a decision tree
C Andres et al.
QSAR & COMBINATORIAL SCIENCE (2006)
Physiological and pathophysiological aspects of ceramide
E Gulbins et al.
AMERICAN JOURNAL OF PHYSIOLOGY-REGULATORY INTEGRATIVE AND COMPARATIVE PHYSIOLOGY (2006)
Ceramide involvement in apoptosis and apoptotic diseases
Karin Thevissen et al.
MINI-REVIEWS IN MEDICINAL CHEMISTRY (2006)
In silico prediction of blood brain barrier permeability: An artificial neural network model
P Garg et al.
JOURNAL OF CHEMICAL INFORMATION AND MODELING (2006)
High activity of acid sphingomyelinase in major depression
J Kornhuber et al.
JOURNAL OF NEURAL TRANSMISSION (2005)
A lipid analogue that inhibits sphingomyelin hydrolysis and synthesis, increases ceramide, and leads to cell death
PI Darroch et al.
JOURNAL OF LIPID RESEARCH (2005)
Estimation of the Youden index and its associated cutoff point
R Fluss et al.
BIOMETRICAL JOURNAL (2005)
A recursive-partitioning model for blood-brain barrier permeation
SR Mente et al.
JOURNAL OF COMPUTER-AIDED MOLECULAR DESIGN (2005)
SuperDrug: a conformational drug database
A Goede et al.
BIOINFORMATICS (2005)
In silico ADME modelling: prediction models for blood-brain barrier permeation using a systematic variable selection method
R Narayanan et al.
BIOORGANIC & MEDICINAL CHEMISTRY (2005)
A novel high-throughput screening format to identify inhibitors of secreted acid sphingomyelinase
RJ Mintzer et al.
JOURNAL OF BIOMOLECULAR SCREENING (2005)
Interactions of acid sphingomyelinase and lipid bilayers in the presence of the tricyclic antidepressant desipramine
M Kölzer et al.
FEBS LETTERS (2004)
PAF-mediated pulmonary edema:: a new role for acid sphingomyelinase and ceramide
R Göggel et al.
NATURE MEDICINE (2004)
Differential transactivation of sphingosine-1-phosphate receptors modulates NGF-induced neurite extension
RE Toman et al.
JOURNAL OF CELL BIOLOGY (2004)
The complex life of simple sphingolipids
AH Futerman et al.
EMBO REPORTS (2004)
Acid sphingomyelinase and inhibition by phosphate ion:: role of inhibition by phosphatidyl-myo-inositol 3,4,5-triphosphate in oligodendrocyte cell signaling
FD Testai et al.
JOURNAL OF NEUROCHEMISTRY (2004)
Phosphatidylinositol-3,5-bisphosphate is a potent and selective inhibitor of acid sphingomyelinase
M Kölzer et al.
BIOLOGICAL CHEMISTRY (2003)
Role of sphingomyelin-MAPKs pathway in heat-induced apoptosis
HS Chung et al.
EXPERIMENTAL AND MOLECULAR MEDICINE (2003)
The importance of being earnest: Validation is the absolute essential for successful application and interpretation of QSPR models
A Tropsha et al.
QSAR & COMBINATORIAL SCIENCE (2003)
Host defense against Pseudomonas aeruginosa requires ceramide-rich membrane rafts
H Grassmé et al.
NATURE MEDICINE (2003)
Random forest: A classification and regression tool for compound classification and QSAR modeling
V Svetnik et al.
JOURNAL OF CHEMICAL INFORMATION AND COMPUTER SCIENCES (2003)
Ceramide pathways modulate ethanol-induced cell death in astrocytes
M Pascual et al.
JOURNAL OF NEUROCHEMISTRY (2003)
Substantial sulfatide deficiency and ceramide elevation in very early Alzheimer's disease: potential role in disease pathogenesis
XL Han et al.
JOURNAL OF NEUROCHEMISTRY (2002)
Sphingosine 1-phosphate, a key cell signaling molecule.
S Spiegel et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2002)
Sphingomyelinase and ceramide analogs induce vasoconstriction and leukocyte-endothelial interactions in cerebral venules in the intact rat brain: Insight into mechanisms and possible relation to brain injury and stroke
BM Altura et al.
BRAIN RESEARCH BULLETIN (2002)
Modeling blood-brain barrier partitioning using the electrotopological state
K Rose et al.
JOURNAL OF CHEMICAL INFORMATION AND COMPUTER SCIENCES (2002)
Breaking up is hard to do: The heartbreak of dichotomizing continuous data
DL Streiner
CANADIAN JOURNAL OF PSYCHIATRY-REVUE CANADIENNE DE PSYCHIATRIE (2002)
Computational approaches to the prediction of the blood-brain distribution
U Norinder et al.
ADVANCED DRUG DELIVERY REVIEWS (2002)
Development of quantitative structure-property relationship models for early ADME evaluation in drug discovery. 2. Blood-brain barrier penetration
RF Liu et al.
JOURNAL OF CHEMICAL INFORMATION AND COMPUTER SCIENCES (2001)
Correlation and prediction of a large blood-brain distribution data set - an LFER study
JA Platts et al.
EUROPEAN JOURNAL OF MEDICINAL CHEMISTRY (2001)
Endothelial apoptosis as the primary lesion initiating intestinal radiation damage in mice
F Paris et al.
SCIENCE (2001)
CD95 signaling via ceramide-rich membrane rafts
H Grassmé et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2001)
Role of the sphingosine-1-phosphate receptor EDG-1 in PDGF-induced cell motility
JP Hobson et al.
SCIENCE (2001)
Pivotal role for acidic sphingomyelinase in cerebral ischemia-induced ceramide and cytokine production, and neuronal apoptosis
ZF Yu et al.
JOURNAL OF MOLECULAR NEUROSCIENCE (2000)
A simple model for the prediction of blood-brain partitioning
M Feher et al.
INTERNATIONAL JOURNAL OF PHARMACEUTICS (2000)
Apoptosis modulators in the therapy of neurodegenerative diseases
HP Deigner et al.
EXPERT OPINION ON INVESTIGATIONAL DRUGS (2000)
Ceramide in the eukaryotic stress response
YA Hannun et al.
TRENDS IN CELL BIOLOGY (2000)